Search
for
Sort by
Research 481–510 of 1000+
- Dual blockage of P-cadherin and c-Met synergistically inhibits the growth of head and neck cancer
- Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
- Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis
- Hypoxia-Derived Mesenchymal Stem Cell Exosomes Downregulate CXCL12 and Upregulate IL-10 Expression in a Murine Model of Androgenic Alopecia
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata
- Inhibition of 5α-Reductase, IL-6 Secretion, and Oxidation Process of Equisetum debile Roxb. ex Vaucher Extract as Functional Food and Nutraceuticals Ingredients
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Targeting lymphoid-derived IL-17 signaling to delay skin aging
- Age-associated inflammation inhibits epidermal stem cell function
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- A Cell Membrane-Level Approach to Cicatricial Alopecia Management: Is Caveolin-1 a Viable Therapeutic Target in Frontal Fibrosing Alopecia?
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Evaluation of New Pregnane Derivatives as 5.ALPHA.-Reductase Inhibitor.
- Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Adenosine Promotes Human Hair Growth and Inhibits Catagen Transition In Vitro: Role of the Outer Root Sheath Keratinocytes
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- Increase in IL-15 levels in patients with alopecia areata
- Aromatase inhibitor–induced hair loss in two adolescents
- Medicaid coverage of Janus kinase inhibitors for alopecia areata treatment
- Das weiße Hautfettgewebe initiiert die IL-33-abhängige Expression von Interleukin 4/13 in myeloischen Zellen während einer Entzündung
- Physiological Doses of Red Light Induce IL‐4 Release in Cocultures between Human Keratinocytes and Immune Cells
- 875 A novel animal model of Desmoglein 1 (Dsg1) deficiency reveals an essential role for Dsg1 in epidermal barrier formation
- The evaluation of IL-4 intron 3 VNTR and TNF-α (rs1799964) gene polymorphisms in Egyptian patients with Alopecia Areata: a case-control study
- The evaluation of IL-4 VNTR intron 3 and TNF-α (rs1799964) gene polymorphisms in Egyptian patients with alopecia areata: a case–control study
- Effect of Topical Gel Administration of Secretome Hypoxia Mesenchymal Stem Cells (SH-MSCs) on IL-10 and TNF- α Gene Expression (In Vivo Experimental Study in Male Rats of Wistar Strains Model of Fluconazole-Induced Alopecia)
- 033 IL-15 is an unexpected guardian of hair follicle immune privilege and promotes human hair growth ex vivo